Renewal of license agreement between ExpreS2ion Biotechnologies and the Francis Crick Institute


On August 23 2016 ExpreS2ion Biotechnologies ApS, Horsholm, Denmark (”ExpreS2ion”) and the Francis Crick Institute, London, United Kingdom, announce that they have amended their Research License Agreement to extend the research based on ExpreS2ion’s proprietary ExpreS2 expression system for another year.

Read the whole news (pdf)